ICON plc | Clinical Research Organisation (CRO) for Drug Development

The Role of ICER as an Independent HTA Organisation

Primary research evaluating ICER’s influence over payers and manufactures

Personalising Digital Health Solutions

Digital health solutions for clinical R&D efficiency and patient outcomes

Making Sense of the Biosimilars Market

Insights you need for successful biosimilar commercialisation

Key Considerations in Chronic Pain Clinical Trials

Determine the right design, assessments and endpoints in your pain study

ICON Insights

17 June 2019

EMA Publishes Second Draft Guideline on New MDR Rules Specifying Quality Requirements for Drug-Device Combinations

Key takeaways from the EMA’s second draft guidance on MDR and its impact on combination products.

10 June 2019

Tackling RWE Challenges to Demonstrate Healthcare Value

Despite multiple challenges, RWE clearly has huge potential to inform healthcare stakeholders.

31 May 2019

Towards a Data-Driven Feasibility Assessment

Explore how conducting a thorough data-driven feasibility assessment sets sponsors up for success in the operational aspects of their trials.

23 May 2019

The Digitization of Clinical Drug Development

ICON expert Dr. Uma Arumugam takes a look at the advancements in digital applications and technology impacting clinical drug development.

18 May 2019

Biosimilar Development in Ophthalmology

ICON experts Bart Chapman and Shanthi Sundaramoorthy answer common questions about ophthalmology studies, and those relating to biosimilars.

17 May 2019

Using Economic Models to Gain Early Access

Early access schemes demand new ways of performing health economic evaluations.

09 May 2019

How Value-Based Healthcare affects Medical Device Development

Manufacturers need to employ new methods and tools to maximise the effectiveness of their efforts in bringing new devices to market.

24 April 2019

5 Common Barriers to Harmonised Real World Data

Learn 5 common barriers to Real World Data (RWD) harmonisation and insights on how to overcome these challenges.

16 April 2019

ePharma IMPACT 2019 Recap

ICON's Travis Tingey attended the recent ePharma IMPACT conference and shares his thoughts on notable trends and themes.

Services

Therapeutics

Innovation

Insights

News & Events

About ICON

Flow Cytometry for Driving Trials Forward

ICON announces the acquisition of MeDiNova Research

Site & Patient Solutions

MDR/IVDR brings higher costs and bottlenecks

Drug Safety Reporting

The Impact of AI on Outcomes Based Contracting